Diagnostics Inc reports results for the quarter ended in March - Earnings Summary

Co-Diagnostics

12/05/2022 22:46

* Co-Diagnostics Inc  CODX.OQ  reported quarterly adjusted
earnings of 34 cents​​ per share for the quarter ended in March.
The mean expectation of three analysts for the quarter was
for earnings of 17 cents per share.
    * Revenue rose 13.4% to $22.70 million from a year ago; 
analysts
expected $21.17 million. 
    * Co-Diagnostics Inc's reported EPS for the quarter was 34
cents​.
    * The mean earnings estimate of analysts had risen by
about 52.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Co-Diagnostics Inc shares had fallen by 39.2% this
quarter and
lost 57.9% so far this year.
    * The company reported quarterly net income of $11.71
million.
    * Wall Street's median 12-month price target for
Co-Diagnostics
Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:45 p.m.  ​All
figures in US dollars unless otherwise stated